Smart insulin system with behavior support for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a smart insulin pump and continuous glucose monitor system that adjusts insulin automatically and uses behavior support to improve blood sugar control. It's for people with type 1 diabetes who have used an approved automated insulin delivery system recently and are willing to use study devices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 1 diabetes for more than one year
- You have used an FDA-approved automated insulin delivery system in the last 6 months
- You have used insulin for more than 6 months
- You have a supportive companion nearby who can help in an emergency
- You are willing to use a Dexcom continuous glucose monitor and the study's phone system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This study tests whether an artificial intelligence (AI) system can help manage insulin pump therapy remotely for people with type 1 diabetes. The goal is to improve blood sugar control and make diabetes management easier.
This trial tests a new experimental automated insulin delivery system (a type of 'artificial pancreas') to see if it is safe and works better than current systems. It may help people whose blood sugar is not well controlled with their current pump or system.
This study looks at whether turning off meal announcements in automated insulin delivery systems (which adjust insulin automatically) is safe and effective for people with type 1 diabetes. It may help simplify daily diabetes management.
This study tests an artificial intelligence feature that helps the insulin pump deliver extra insulin before meals. It aims to improve blood sugar control for adults with type 1 diabetes who already use an automated insulin delivery system.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
Hear when a new Type 1 Diabetes (T1D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.